GlassScriptPhysician profile
Alexander Ivanov
NPI 1770583163
$19,565.36
in general payments reported to CMS, 2019-2025
29 companies · $2,762 in 2025
The $2,762 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,391 · 2020: $480 · 2021: $267 · 2022: $1,099 · 2023: $5,578 · 2024: $6,989 · 2025: $2,762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,498 · Grant: $5,000 · Food and Beverage: $4,673 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,497.64 |
| Grant | $5,000.00 |
| Food and Beverage | $4,673.31 |
| Education | $157.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $12,578.41 | 2021-2025 | Micra, Attain Command + Surevalve, Selectsecure |
| Biosense Webster, INC. | $1,689.18 | 2024-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro |
| Medtronic Vascular, INC. | $1,429.01 | 2019-2020 | |
| Abbott Laboratories | $1,318.80 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx, Tendril |
| Amgen INC. | $309.55 | 2019-2024 | Repatha |
| Biotronik INC. | $237.39 | 2021-2025 | Biomonitor |
| Novartis Pharmaceuticals Corporation | $204.03 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $200.89 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $163.53 | 2019-2025 | |
| Edwards Lifesciences Corporation | $148.78 | 2019 | |
| Janssen Pharmaceuticals, INC | $147.92 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.87 | 2019-2025 | Jardiance |
| Biotronik Nro, INC. | $126.85 | 2025 | Prospera |
| Zimmer Biomet Holdings, INC. | $122.29 | 2024 | Neuro Plating System |
| Astellas Pharma US INC | $99.99 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $97.39 | 2019-2024 | Farxiga |
| Boston Scientific Corporation | $95.87 | 2019-2020 | |
| Esperion Therapeutics, INC. | $73.55 | 2022-2025 | Nexletol |
| Philips North America LLC | $64.71 | 2023 | |
| Bardy Diagnostics, INC. | $61.95 | 2019-2020 | |
| Amarin Pharma, INC. | $54.90 | 2019-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $42.73 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $30.25 | 2022-2023 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $27.61 | 2022-2023 | Arcalyst |
| Acarix USA INC. | $25.95 | 2023 | Cadscor System |
| Sanofi-Aventis U.S. LLC | $25.00 | 2019 | |
| Cvrx, INC. | $24.10 | 2024 | Barostim Neo System |
| Kowa Pharmaceuticals America, INC. | $14.92 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Ivanov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.